References
- Klatt EC, Montgomery S, Namiki T, Noguchi TT. Misrepresentation of stimulant street drugs: a decade of experience in an analysis program. J Toxicol Clin Toxicol 1986; 24:441–450.
- Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med 1988; 17:1243–1247.
- Hamilton RJ, Perrone J, Hoffman R, Henretig FM, Karkevandian EH, Marcus S, Shih RD, Blok B, Nordenholz K. A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. Clin Toxicol 2000; 38:597–608.
- Hoffman RS, Kirrane BM, Marcus SM. A descriptive study of an outbreak of clenbuterol-containing heroin. Ann Emerg Med 2008; 52:548–553.
- Mego DM, Omori DJM, Hanley JF. Transdermal scopolamine as a cause of transient psychosis in two elderly patients. South Med J 1988; 81:394–395.
- Moore AW, Cantab BC. A case of scopolamine poisoning. Lancet 1907; 1084.
- Hanna JP, Schmidley JW, Braselton WEJr. Datura delirium. Clin Neuropharmacol 1992; 15:109–113.
- Hayman J. Datura poisoning – the angel's trumpet. Pathology 1985; 17:465–466.
- Goldfrank L, Flomenbaum N, Lewin L, Weisman R, Howland MA, Kaul B. Anticholinergic poisoning. J Toxicol – Clin Toxicol 1982; 19:17–25.
- Ardila A, Moreno C. Scopolamine intoxication as a model of transient global amnesia. Brain Cogn 1991; 15:236–245.
- Nogué S, Sanz P, Munné P, de la Torre R. Acute scopolamine poisoning after sniffing adulterated cocaine. Drug Alcohol Depend 1991; 27:115–116.
- Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005; 27:655–665.
- Nachum Z, Shahal B, Shupak A, Spitzer O, Gonen A, Beiran I, Lavon H, Eynan M, Dachir S, Levy A. Scopolamine bioavailability in combined oral and transdermal delivery. J Pharmacol Exp Ther 2001; 296:121–123.